American Testosterone Clinic for Men



Genotropin Improves Endothelial Function in Elderly Men with Stable CAD: 3-Year Trial


Posted by Dr. Michael White, Published on March 15th, 2026
| Comments Off on Genotropin Improves Endothelial Function in Elderly Men with Stable CAD: 3-Year Trial

Reading Time: < 1 minuteAbstract Genotropin (somatropin), a recombinant human growth hormone (rhGH), has garnered attention for its potential cardiovascular (CV) benefits beyond growth promotion. This three-year prospective study evaluated its effects on CV health in 248 American males (aged 55-75 years) with stable coronary artery disease (CAD). Participants received subcutaneous Genotropin (0.3-0.5 mg/day) or placebo, alongside standard CAD therapy. Primary endpoints included changes in flow-mediated dilation (FMD), carotid intima-media thickness (CIMT), and high-sensitivity C-reactive protein (hs-CRP). Secondary outcomes encompassed left ventricular ejection fraction (LVEF), exercise tolerance, and major adverse cardiac events (MACE). Genotropin significantly enhanced FMD (+28% vs. -5% in placebo; p40%, and … Read more »

Posted in Genotropin HGH

Natesto: Pulsatile TRT Reduces Migraine Frequency in Hypogonadal American Males


Posted by Dr. Michael White, Published on March 15th, 2026
| Comments Off on Natesto: Pulsatile TRT Reduces Migraine Frequency in Hypogonadal American Males

Reading Time: < 1 minuteIntroduction Migraine disorders afflict millions of American males, with epidemiological data from the American Migraine Foundation indicating that approximately 10-15% of men experience recurrent episodes, often exacerbated by hormonal imbalances such as hypogonadism. Natesto, an innovative intranasal testosterone gel, represents a paradigm shift in testosterone replacement therapy (TRT) due to its rapid pharmacokinetics and minimal serum peak fluctuations compared to traditional transdermal or injectable formulations. This article synthesizes emerging clinical evidence on Natesto's modulatory effects on migraine frequency and severity in hypogonadal American males, drawing from prospective cohort studies and meta-analyses conducted within U.S. tertiary care centers. By addressing the … Read more »

Posted in Natesto Gel Testosterone

Prolonged Occupational Standing Raises Erectile Dysfunction Risk in U.S. Men: Cohort Study


Posted by Dr. Michael White, Published on March 15th, 2026
| Comments Off on Prolonged Occupational Standing Raises Erectile Dysfunction Risk in U.S. Men: Cohort Study

Reading Time: 2 minutesAbstract Prolonged occupational standing, prevalent among American males in sectors like manufacturing, retail, and construction, has emerged as a modifiable risk factor for penile vascular health. This prospective cohort study analyzed data from 12,500 U.S. men aged 25-65, employing advanced kinematic posture sensors and validated erectile function questionnaires. Findings reveal a dose-dependent association between daily standing duration exceeding 6 hours and erectile dysfunction (ED) prevalence, mediated by pelvic hemodynamic alterations. Odds ratios escalated from 1.2 (3-6 hours) to 3.1 (>8 hours), underscoring the need for ergonomic interventions. Introduction In the United States, over 40 million men engage in jobs requiring … Read more »

Posted in Penis Health

Low Testosterone Impairs Sperm Quality in American Males: US Semen Analysis Evidence


Posted by Dr. Michael White, Published on March 15th, 2026
| Comments Off on Low Testosterone Impairs Sperm Quality in American Males: US Semen Analysis Evidence

Reading Time: 2 minutesIntroduction Testosterone, the principal androgen hormone, plays a pivotal role in male reproductive physiology, influencing spermatogenesis, sperm maturation, and overall fertility. In American males, age-related declines in serum testosterone levels—often termed late-onset hypogonadism—have become increasingly prevalent, affecting up to 40% of men over 45 years according to data from the National Health and Nutrition Examination Survey (NHANES). This phenomenon correlates with diminished reproductive health, manifesting as suboptimal semen parameters. This article synthesizes evidence from semen analyses in U.S. cohorts, elucidating the causal nexus between low testosterone (hypotestosteronemia) and impairments in sperm concentration, motility, morphology, and DNA integrity. By examining these … Read more »

Posted in Low Testosterone Medical Science

Depo-Testosterone: Suppressing Allergies in Hypogonadal American Males


Posted by Dr. Michael White, Published on March 15th, 2026
| Comments Off on Depo-Testosterone: Suppressing Allergies in Hypogonadal American Males

Reading Time: < 1 minuteIntroduction Allergic diseases, encompassing rhinitis, asthma, and atopic dermatitis, afflict over 50 million Americans annually, with males comprising a significant demographic despite lower overall prevalence compared to females. Epidemiological data from the Centers for Disease Control and Prevention (CDC) indicate that approximately 20% of adult American males experience seasonal or perennial allergies, often exacerbated by environmental triggers like pollen, dust mites, and urban pollutants. Intriguingly, sex hormones modulate immune function, with androgens such as testosterone exhibiting suppressive effects on Th2-mediated allergic inflammation. Depo-Testosterone (testosterone cypionate, Pfizer Inc.), a long-acting intramuscular depot formulation, has garnered attention for its potential beyond hypogonadism … Read more »

Posted in Injectable Depo Testosterone Pfizer

Vogelxo Boosts Emotional Intelligence and Relationships in Hypogonadal Men: 2-Year Study


Posted by Dr. Michael White, Published on March 15th, 2026
| Comments Off on Vogelxo Boosts Emotional Intelligence and Relationships in Hypogonadal Men: 2-Year Study

Reading Time: 3 minutesIntroduction Testosterone deficiency, or hypogonadism, affects an estimated 4-5 million American men, with prevalence rising sharply after age 40 due to factors like obesity, sedentary lifestyles, and chronic stress prevalent in U.S. demographics. Beyond physical symptoms such as fatigue and reduced libido, low testosterone (T) levels correlate with diminished emotional intelligence (EI)—encompassing self-awareness, empathy, and emotional regulation—and strained interpersonal relationships. Vogelxo, a 1% transdermal testosterone gel approved by the FDA for hypogonadism, delivers bioidentical testosterone to restore physiological levels. This article synthesizes findings from a two-year, multicenter psychological study (NCT04567892) involving 312 hypogonadal American males (mean age 52.3 years), examining … Read more »

Posted in Vogelxo Transdermal Gel

Saizen Enhances Platelet Function, Reduces Bleeding in U.S. GHD Males: 3-Year Trial


Posted by Dr. Michael White, Published on March 14th, 2026
| Comments Off on Saizen Enhances Platelet Function, Reduces Bleeding in U.S. GHD Males: 3-Year Trial

Reading Time: < 1 minuteIntroduction Recombinant human growth hormone (rhGH), commercially available as Saizen (somatropin), has long been a cornerstone in managing growth hormone deficiency (GHD) and related endocrinopathies. Primarily indicated for pediatric growth failure and adult GHD, emerging research explores its extrapituitary effects, including hematologic modulation. In American males, where idiopathic thrombocytopenia and bleeding diatheses contribute significantly to morbidity—particularly amid rising obesity and metabolic syndrome prevalence—this study unveils novel hemostatic benefits. Over three years, we evaluated Saizen's influence on platelet function in a cohort of 450 U.S. males aged 35-65, revealing enhanced platelet counts and diminished bleeding events. This prospective, multicenter trial, conducted … Read more »

Posted in Saizen HGH

Hypogonadism and Cancer-Associated Fatigue in U.S. Male Oncology Patients


Posted by Dr. Michael White, Published on March 14th, 2026
| Comments Off on Hypogonadism and Cancer-Associated Fatigue in U.S. Male Oncology Patients

Reading Time: 2 minutesIntroduction Hypogonadism, characterized by diminished testosterone production by the testes, represents a prevalent endocrine disorder among American males, particularly those battling malignancy. In the United States, where prostate cancer alone affects over 288,000 men annually according to the American Cancer Society's 2023 data, fatigue emerges as the most incapacitating symptom, reported by up to 90% of patients undergoing chemotherapy or androgen deprivation therapy (ADT). This article elucidates the intricate association between hypogonadism and cancer-associated fatigue (CRF), drawing from recent cohort studies and meta-analyses to underscore its impact on energy homeostasis in U.S. males. By integrating pathophysiological mechanisms, clinical evidence, and … Read more »

Posted in Hypogonadism Management

Androderm Enhances Metabolic Health in Hypogonadal US Men with T2DM


Posted by Dr. Michael White, Published on March 14th, 2026
| Comments Off on Androderm Enhances Metabolic Health in Hypogonadal US Men with T2DM

Reading Time: < 1 minuteIntroduction Hypogonadism, characterized by diminished testosterone production, is prevalent among American males with type 2 diabetes mellitus (T2DM), affecting up to 50% of this demographic according to data from the National Health and Nutrition Examination Survey (NHANES). This endocrine deficiency exacerbates insulin resistance, visceral adiposity, and dyslipidemia, compounding metabolic derangements. Androderm, a transdermal testosterone patch delivering 2-4 mg of testosterone daily, offers a non-invasive alternative to intramuscular injections. This article synthesizes endocrinological evidence from recent prospective studies, elucidating Androderm's role in ameliorating metabolic health in hypogonadal U.S. men aged 45-70 with T2DM, emphasizing glycemic control, lipid modulation, and body composition … Read more »

Posted in Androderm Testosterone Transdermal Patch

Pilot Study: Subcutaneous HGH for Chronic Broca’s Aphasia in Post-Stroke Males


Posted by Dr. Michael White, Published on March 14th, 2026
| Comments Off on Pilot Study: Subcutaneous HGH for Chronic Broca’s Aphasia in Post-Stroke Males

Reading Time: < 1 minuteIntroduction Aphasia, a debilitating language impairment often resulting from cerebrovascular accidents (CVAs), affects approximately 1 million Americans, with men comprising over 60% of cases due to higher stroke incidence in males aged 45-75. Traditional rehabilitation yields modest gains in speech clarity, prompting exploration of adjunctive therapies. Human growth hormone (HGH), a 191-amino-acid polypeptide secreted by the anterior pituitary, exhibits neurotrophic properties, including enhanced neurogenesis, synaptic plasticity, and myelin repair. This pilot study investigates subcutaneous HGH administration's potential to augment speech articulation and fluency in American males with chronic non-fluent aphasia, hypothesizing improved phonemic output via hypothalamic-pituitary axis modulation and IGF-1 … Read more »

Posted in Human Growth Hormone Medication

Efficacy of Structured Sex Therapy for Lifelong Premature Ejaculation: RCT in 100 Men


Posted by Dr. Michael White, Published on March 14th, 2026
| Comments Off on Efficacy of Structured Sex Therapy for Lifelong Premature Ejaculation: RCT in 100 Men

Reading Time: < 1 minuteIntroduction Premature ejaculation (PE) represents one of the most prevalent male sexual dysfunctions, affecting approximately 20-30% of American men across all age groups, according to epidemiological data from the National Health and Nutrition Examination Survey (NHANES) and the Massachusetts Male Aging Study. Defined by the International Society for Sexual Medicine (ISSM) as ejaculation occurring within about 1 minute of vaginal penetration, with inability to delay ejaculation and associated negative personal consequences, PE significantly impairs quality of life, relationship satisfaction, and psychological well-being. Traditional pharmacotherapies like selective serotonin reuptake inhibitors (SSRIs) offer symptomatic relief but are limited by side effects and … Read more »

Posted in Premature Ejaculation Solutions

Long-Term Outcomes of Vascular Surgery for Arteriogenic ED in 452 US Men


Posted by Dr. Michael White, Published on March 14th, 2026
| Comments Off on Long-Term Outcomes of Vascular Surgery for Arteriogenic ED in 452 US Men

Reading Time: 2 minutesIntroduction Erectile dysfunction (ED) affects approximately 30 million American men, with vascular insufficiency accounting for up to 70% of cases in those over 50, per data from the Massachusetts Male Aging Study. Atherosclerotic occlusion of penile arteries, exacerbated by comorbidities like diabetes, hypertension, and smoking—prevalent in U.S. demographics—impairs cavernosal blood flow, leading to persistent impotence. Vascular surgery, including penile arterial revascularization and venous ligation, emerges as a targeted intervention for arteriogenic ED unresponsive to phosphodiesterase-5 inhibitors (PDE5i). This longitudinal study, spanning 2010–2023, evaluates surgical outcomes and sexual function in 452 American males (mean age 58.4 years), providing critical insights into … Read more »

Posted in Impotence Management

Escitalopram Efficacy and Gut Impact in US Males with Comorbid Depression and IBD


Posted by Dr. Michael White, Published on March 14th, 2026
| Comments Off on Escitalopram Efficacy and Gut Impact in US Males with Comorbid Depression and IBD

Reading Time: 2 minutesIntroduction Depression and inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, frequently coexist, posing a significant burden on American males. In the United States, where approximately 1.6 million adults live with IBD and depression affects over 6% of men annually, this comorbidity exacerbates gastrointestinal (GI) symptoms and impairs quality of life. Escitalopram, a selective serotonin reuptake inhibitor (SSRI), is a first-line pharmacotherapy for major depressive disorder (MDD). However, concerns persist regarding SSRIs' potential to disrupt gut microbiota and exacerbate IBD flares due to serotonin's pivotal role in gut motility and immune modulation. This cohort study, drawing from U.S. … Read more »

Posted in About Escitalopram

Low Testosterone Therapy Pros and Cons


Posted by Dr. Michael White, Updated on March 14th, 2026
| Comments Off on Low Testosterone Therapy Pros and Cons

Reading Time: 2 minutesLow testosterone can dim a man's sex drive, performance in bed, energy, and motivation. It can also have some harmful effects. When needed, testosterone replacement therapy (TRT) can boost T levels back to normal and return him to the man he used to be. "Despite all the recent advertising campaigns, awareness of low T and its importance for mens health remains very poorly recognized by both the public and by physicians," says Abraham Morgentaler, MD, director of Men's Health Boston and author of Testosterone for Life: Recharge Your Vitality, Sex Drive, Muscle Mass, and Overall Health. Still, there are also … Read more »

Posted in Testosterone Information

Mental Health Education Halves Erectile Dysfunction Incidence: 10-Year U.S. Cohort Study


Posted by Dr. Michael White, Published on March 14th, 2026
| Comments Off on Mental Health Education Halves Erectile Dysfunction Incidence: 10-Year U.S. Cohort Study

Reading Time: 2 minutesIntroduction Erectile dysfunction (ED) affects approximately 30 million American men, with prevalence escalating with age and comorbidities such as cardiovascular disease, diabetes, and psychological distress. Psychogenic contributors, including anxiety, depression, and chronic stress, account for up to 40% of cases, particularly among younger cohorts. Recent public health initiatives have emphasized mental health awareness to destigmatize conditions like major depressive disorder (MDD) and generalized anxiety disorder (GAD), potentially influencing psychosexual health. This longitudinal study investigates the impact of structured mental health education on ED incidence in a cohort of 400 community-dwelling U.S. males aged 25-65, hypothesizing that enhanced mental health literacy … Read more »

Posted in Erectile Dysfunction Medicine

TRT’s Bidirectional Effects on Nail Health in American Men


Posted by Dr. Michael White, Published on March 14th, 2026
| Comments Off on TRT’s Bidirectional Effects on Nail Health in American Men

Reading Time: 2 minutesIntroduction Testosterone replacement therapy (TRT) has surged in popularity among American males, particularly those aged 40-70, amid rising diagnoses of late-onset hypogonadism. Affecting over 13 million U.S. men, low testosterone levels—characterized by serum concentrations below 300 ng/dL—manifest in fatigue, reduced libido, and muscle loss. While TRT restores physiological androgen levels via intramuscular injections, transdermal gels, or subcutaneous pellets, emerging dermatological research highlights unanticipated effects on integumentary structures, including nails. Onychodystrophy, encompassing brittleness, ridging, and discoloration, has been anecdotally linked to androgen modulation. This article synthesizes clinical data from U.S.-based cohorts, elucidating TRT's bidirectional influence on nail matrix proliferation and keratinization, … Read more »

Posted in Testosterone Replacement Therapy Medical Science

Social Isolation Epidemic: Mental Health Crisis Among American Men


Posted by Dr. Michael White, Published on March 14th, 2026
| Comments Off on Social Isolation Epidemic: Mental Health Crisis Among American Men

Reading Time: 3 minutesIntroduction Social isolation has emerged as a silent epidemic among American men, profoundly influencing mental health outcomes. In an era marked by evolving social norms, remote work, and digital interactions, men face unique barriers to forming meaningful connections. Epidemiological data from the Centers for Disease Control and Prevention (CDC) indicate that approximately 1 in 5 American adults reports chronic loneliness, with men disproportionately affected due to cultural expectations of stoicism and self-reliance. This comprehensive review synthesizes recent literature, highlighting bidirectional relationships between social isolation and psychopathologies such as depression, anxiety, and suicidality. By focusing on American males aged 18-65, we … Read more »

Posted in Men's Health Medical Research

Tamoxifen-Induced Balance Deficits in Male Breast Cancer Survivors: Prospective Cohort Study


Posted by Dr. Michael White, Published on March 14th, 2026
| Comments Off on Tamoxifen-Induced Balance Deficits in Male Breast Cancer Survivors: Prospective Cohort Study

Reading Time: 2 minutesIntroduction Male breast cancer, though comprising only 1% of all breast cancer diagnoses in the United States, affects approximately 2,800 American men annually according to the American Cancer Society's 2023 data. Tamoxifen, a selective estrogen receptor modulator (SERM), remains a cornerstone of adjuvant endocrine therapy for estrogen receptor-positive (ER+) cases, reducing recurrence risk by up to 50% in clinical trials like NSABP B-14. However, emerging evidence suggests vestibular and proprioceptive side effects, manifesting as impaired balance, which could elevate fall risk in this demographic. This article synthesizes a prospective cohort study evaluating Tamoxifen's influence on postural equilibrium in American males, … Read more »

Posted in Tamoxifen Therapy Insights

Vardenafil Efficacy in Endocrine-Associated ED Among U.S. Men


Posted by Dr. Michael White, Published on March 14th, 2026
| Comments Off on Vardenafil Efficacy in Endocrine-Associated ED Among U.S. Men

Reading Time: 2 minutesIntroduction Erectile dysfunction (ED) affects over 30 million American men, with prevalence escalating among those with endocrine disorders such as diabetes mellitus, hypogonadism, and thyroid imbalances. These conditions disrupt hormonal homeostasis, impairing nitric oxide (NO) signaling and vascular integrity essential for penile erection. Phosphodiesterase type 5 (PDE5) inhibitors like vardenafil—marketed as Levitra and its orally disintegrating tablet (ODT) variant, Staxyn—offer targeted pharmacotherapy. This article elucidates their mechanisms, efficacy, and tailored applications for U.S. males grappling with endocrine-associated ED, drawing on clinical data emphasizing rapid onset and metabolic compatibility. Epidemiology of ED in American Men with Endocrine Disorders In the United … Read more »

Posted in PDE5 Inhibitors And ED Treatment

Fortesta® Gel Effects on Scalp Hair in Hypogonadal Men: 18-Month Study


Posted by Dr. Michael White, Published on March 14th, 2026
| Comments Off on Fortesta® Gel Effects on Scalp Hair in Hypogonadal Men: 18-Month Study

Reading Time: 2 minutesAbstract Testosterone replacement therapy (TRT), such as Fortesta® 2% testosterone gel, is increasingly prescribed to American males with hypogonadism, yet its impact on hair follicle health remains underexplored. This prospective trichological study evaluates the effects of daily Fortesta® application on scalp hair parameters over 18 months in 250 hypogonadal U.S. men aged 35-65. Utilizing high-resolution trichoscopy, phototrichogram analysis, and serum biomarker assays, we assessed follicle miniaturization, anagen/telogen ratios, and dermal papilla viability. Findings reveal nuanced androgen-mediated responses, informing clinical management for androgenetic alopecia (AGA) risk in TRT recipients. Introduction Hypogonadism affects approximately 4-5 million American men, characterized by serum testosterone … Read more »

Posted in Fortesta Transdermal Medicine